Brief: Dynavax Technologies Corp - Q2 Revenue Of $256.5 Mln, Up 386%
Aug 4 (Reuters) - Dynavax Technologies Corp DVAX.O :
* DYNAVAX REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
* Q2 2022 TOTAL REVENUE OF $256.5 MILLION, UP 386% FROM $52.8 MILLION FOR Q2
2021
* GAAP NET INCOME WAS $128.8 MILLION, OR $1.02 PER SHARE (BASIC) AND $0.87
PER
SHARE (DILUTED) IN Q2 OF 2022
* Q2 REVENUE VIEW $151.0 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn4GWGPXa
Further company coverage: DVAX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dynavax Technologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
OneSpaWorld jumps as co poised to join S&P SmallCap index
Sanofi targets high single digit sales growth in 2026, plans share buyback (updated)
Focus: Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality